These companies focused as much on cod liver oil, toothpaste, citric acid for soft drinks, and hair gel as on prescription medicines, as well as selling products like heroin on the over-the ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a ...

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

The INSIGHT-003 trial in non-small cell lung cancer showed that its drug eftilagimod alpha (efti), when combined with ...

I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo editing software, and how operating systems change over time. I was ...

I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo editing software, and how operating systems change over time. I was ...

Merck is one of the world's largest pharmaceutical companies, and its leading products include cancer drug Keytruda and HPV vaccine Gardasil. Analyst Charlie Yang projects declining Gardasil sales ...